JP2012524772A5 - - Google Patents

Download PDF

Info

Publication number
JP2012524772A5
JP2012524772A5 JP2012506584A JP2012506584A JP2012524772A5 JP 2012524772 A5 JP2012524772 A5 JP 2012524772A5 JP 2012506584 A JP2012506584 A JP 2012506584A JP 2012506584 A JP2012506584 A JP 2012506584A JP 2012524772 A5 JP2012524772 A5 JP 2012524772A5
Authority
JP
Japan
Prior art keywords
composition
triglycerides
omega
pharmaceutical composition
buccal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012506584A
Other languages
English (en)
Japanese (ja)
Other versions
JP5795760B2 (ja
JP2012524772A (ja
Filing date
Publication date
Priority claimed from PCT/GB2009/050415 external-priority patent/WO2010122275A1/en
Priority claimed from GB0906971.7A external-priority patent/GB2469791B/en
Application filed filed Critical
Priority claimed from PCT/GB2010/050672 external-priority patent/WO2010122356A1/en
Publication of JP2012524772A publication Critical patent/JP2012524772A/ja
Publication of JP2012524772A5 publication Critical patent/JP2012524772A5/ja
Application granted granted Critical
Publication of JP5795760B2 publication Critical patent/JP5795760B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012506584A 2009-04-23 2010-04-23 ジヒドロアルテミシニンを含む舌下スプレー用製剤 Expired - Fee Related JP5795760B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
PCT/GB2009/050415 WO2010122275A1 (en) 2009-04-23 2009-04-23 Pharmaceutical preparation
GB0906971.7A GB2469791B (en) 2009-04-23 2009-04-23 Transmucosal formulation of compounds providing dihydroartemesinin for use in the treatment of neoplastic disease
GB0906971.7 2009-04-23
GBPCT/GB2009/050415 2009-04-23
PCT/GB2010/050672 WO2010122356A1 (en) 2009-04-23 2010-04-23 Sublingual spray formulation comprising dihydroartemesinin

Publications (3)

Publication Number Publication Date
JP2012524772A JP2012524772A (ja) 2012-10-18
JP2012524772A5 true JP2012524772A5 (enrdf_load_stackoverflow) 2013-05-02
JP5795760B2 JP5795760B2 (ja) 2015-10-14

Family

ID=42244197

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012506584A Expired - Fee Related JP5795760B2 (ja) 2009-04-23 2010-04-23 ジヒドロアルテミシニンを含む舌下スプレー用製剤

Country Status (23)

Country Link
US (4) US20120157518A1 (enrdf_load_stackoverflow)
EP (1) EP2424523B1 (enrdf_load_stackoverflow)
JP (1) JP5795760B2 (enrdf_load_stackoverflow)
CN (1) CN102395362B (enrdf_load_stackoverflow)
AU (1) AU2010240654C1 (enrdf_load_stackoverflow)
BR (1) BRPI1014887A8 (enrdf_load_stackoverflow)
CA (1) CA2756925A1 (enrdf_load_stackoverflow)
DK (1) DK2424523T3 (enrdf_load_stackoverflow)
ES (1) ES2390046T3 (enrdf_load_stackoverflow)
HR (1) HRP20120711T1 (enrdf_load_stackoverflow)
IL (1) IL215453A (enrdf_load_stackoverflow)
ME (1) ME02008B (enrdf_load_stackoverflow)
MX (1) MX2011010961A (enrdf_load_stackoverflow)
MY (1) MY155646A (enrdf_load_stackoverflow)
NZ (1) NZ595469A (enrdf_load_stackoverflow)
PL (1) PL2424523T3 (enrdf_load_stackoverflow)
PT (1) PT2424523E (enrdf_load_stackoverflow)
RS (1) RS52430B (enrdf_load_stackoverflow)
RU (1) RU2501550C2 (enrdf_load_stackoverflow)
SG (1) SG175162A1 (enrdf_load_stackoverflow)
SI (1) SI2424523T1 (enrdf_load_stackoverflow)
WO (1) WO2010122356A1 (enrdf_load_stackoverflow)
ZA (1) ZA201107088B (enrdf_load_stackoverflow)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0720967D0 (en) * 2007-10-25 2007-12-05 Protophama Ltd Anti-material pharmaceutical composition
SG175160A1 (en) * 2009-04-23 2011-11-28 Londonpharma Ltd Sublingual pharmaceutical composition comprising a neutral oil
CA2898113C (en) * 2013-01-14 2022-05-31 Health Clinics Limited Combination cancer therapeutics and uses thereof
US20170326102A1 (en) 2014-11-27 2017-11-16 Cipla Limited Pharmaceutical Composition Comprising an Artemisinin Derivative for Nasal or Pulmonary Delivery
JP2020033304A (ja) * 2018-08-30 2020-03-05 医療法人ふじいやさか 薬剤又はサプリメント、組成物、及び水素供給器の使用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030082107A1 (en) * 1997-10-01 2003-05-01 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer
CH692321A5 (de) * 1997-11-03 2002-05-15 Mepha Ag Pharmazeutisch wirksame Zusammensetzung, welche eine gegen Malariaparasiten wirksame Substanz enthält.
RU2236413C2 (ru) * 1998-07-14 2004-09-20 Байер Акциенгезельшафт Производные артемизинина, способ их получения, фармацевтическая композиция на их основе и способ лечения
EP1351678A2 (en) * 2001-01-02 2003-10-15 Elizabeth Shanahan-Prendergast Treatment for inhibiting neoplastic lesions using incensole and/or furanogermacrens
WO2003101357A1 (en) * 2002-05-31 2003-12-11 University Of Mississippi Transmucosal delivery of cannabinoids
CN101843904A (zh) * 2002-06-06 2010-09-29 华盛顿大学 使用青蒿素样化合物预防或延缓癌症显现的方法
WO2004075921A1 (en) * 2003-02-26 2004-09-10 Vrije Universiteit Brussel Inclusion complex of artemisinin or derivates thereof with cyclodextrins
US20060084675A1 (en) * 2004-10-18 2006-04-20 Thomas Efferth Combined treatment with artesunate and an epidermal growth factor receptor kinase inhibitor
US20060233895A1 (en) * 2005-04-15 2006-10-19 Brown Paul R Herbal remedy for treating Lyme disease
PL1933809T3 (pl) * 2005-10-11 2012-09-28 Yissum Research Development Company Of The Hebrew Univ Of Jerusalem Kompozycje do dostarczania donosowego
CN100418524C (zh) * 2005-10-26 2008-09-17 重庆医药工业研究院有限责任公司 一种稳定的青蒿素及青蒿素衍生物的药物组合物

Similar Documents

Publication Publication Date Title
JP2022180461A5 (enrdf_load_stackoverflow)
JP2011500781A5 (enrdf_load_stackoverflow)
JP5822991B2 (ja) 毒性を減少し、そして疾病を治療又は予防するための化合物、組成物及び方法
JP2013511496A5 (enrdf_load_stackoverflow)
ES2564936T3 (es) Aerosol nasal líquido que contiene naltrexona a dosis baja
JP2015528491A5 (enrdf_load_stackoverflow)
AR065579A1 (es) Mejoras en composiciones medicinales o relativas a las mismas
JP2016517434A5 (enrdf_load_stackoverflow)
EA200802012A1 (ru) Фармацевтические препараты в форме раствора для дозирующих ингаляторов под давлением
JP2013542247A5 (enrdf_load_stackoverflow)
NZ605887A (en) Pharmaceutical dosage form comprising 6’-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4’,9’-dihydro-3’h-spiro[cyclohexane-1,1’-pyrano[3,4,b]indol]-4-amine for the treatment of neuropathic pain
WO2007012019A3 (en) Medicaments containing famotidine and ibuprofen and administration of same
JP2012524772A5 (enrdf_load_stackoverflow)
JP2013541583A5 (enrdf_load_stackoverflow)
AR065580A1 (es) Mejoras en composiciones medicinales o relativas a las mismas
WO2017092230A1 (zh) 双黄酮化合物及其治疗癌症和制备药物的用途
RU2011139637A (ru) Сублингвальная спреевая композиция, содержащая дигидроартемизинин
JP2015507020A5 (enrdf_load_stackoverflow)
JP2013523740A5 (enrdf_load_stackoverflow)
WO2015009731A3 (en) Azacyclic constrained analogs of fty720
JP2016505050A5 (enrdf_load_stackoverflow)
US20220305223A1 (en) Olfactory Delivery Device, System and Method for the Delivery of a Variety of Pharmaceutical Agents
RU2012108144A (ru) Противораковая терапия, направленная против раковых стволовых клеток и форм рака, устойчивых к лечению лекарственными препаратами
PE20130782A1 (es) Composiciones farmaceuticas que consisten de paracetamol y el proceso para la preparacion del mismo
CN104869986A (zh) 用于癌症的组合疗法